 SOMERSET, N.J.--BUSINESS WIRE--Catalent, Inc. NYSE: CTLT, the leading global provider of development sciences and manufacturing platforms for medicines, including biotherapeutics; cell and gene therapies; and consumer health products, today announced that it will release financial results for the first quarter of fiscal year 2022 ended September 30, 2021, before the market open on Tuesday, November 2, 2021. The Companys management will host a webcast to discuss the results at 8:15 a.m. ET 